WASHINGTON (Reuters) - U.S. health regulators said on Wednesday they would limit the use of Stryker Corp's artery-opening stent for the brain, based on new data and safety information. The Food and Drug Administration changed the label for the stent, called the Wingspan system, after outside advisers to the agency in March recommended the device should not be used in most people. Stryker's stent is already not widely used. The company has said it sells less than 2,000 devices each year. ... Credit of the story
No comments:
Post a Comment